ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/016/SRR18791516/SRR18791516.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/033/SRR18791533/SRR18791533.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/019/SRR18791519/SRR18791519.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/022/SRR18791522/SRR18791522.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/024/SRR18791524/SRR18791524.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/021/SRR18791521/SRR18791521.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/017/SRR18791517/SRR18791517.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/032/SRR18791532/SRR18791532.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/030/SRR18791530/SRR18791530.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/028/SRR18791528/SRR18791528.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/026/SRR18791526/SRR18791526.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/034/SRR18791534/SRR18791534.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/023/SRR18791523/SRR18791523.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/018/SRR18791518/SRR18791518.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/029/SRR18791529/SRR18791529.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/025/SRR18791525/SRR18791525.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/020/SRR18791520/SRR18791520.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/027/SRR18791527/SRR18791527.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR187/031/SRR18791531/SRR18791531.fastq.gzprimaryOK200GenomicsHuaian Maternity and Child Health Care Hospitalhttps://www.ebi.ac.uk/ena/browser/view/PRJNA827104To investigate the effect of FXR activation, bile-duct-ligation rats were treated with obeticholic acid (OCA [5 mg/kg/day]) or vehicle (0.5% methyl cellulose) per oral gavage for 14 days.Gut Microbiome was determined by 16S rDNA MiSeq sequencing.ENADSP1747, Rat, 6alpha-ethyl-3alpha, intestinum ileum, INT-747, norvegicus, Laboratory, Norway Rat, T1G11_20, Rattus, cholan-24-oic acid, Norway Rats, 7alpha-dihydroxy-5beta-cholan-24-oic acid, lower intestine, BODENLOS, rat, Rattus sp. strain Wistar, Mus norvegicus, 7alpha)-, Rattus norwegicus, Rats, 6-ECDCA, Laboratory Rats, 6-ethyl chenodeoxycholic acid, Norway rat, Rattus rattiscus, (3alpha, 7-dihydroxy-, 5beta, indole-3-acetic acid inducible 12, brown rat, 6-ethyl-3, INT 747, distal intestine, 6alpha, Rattus norvegicus, INT747, BDL, Ocaliva, posterior intestine, rats, DSP-1747, 6ECDCA, Laboratory Rat., 7-dihydroxycholan-24-oic acid, T1G11.20, Norway, 6alpha-ethyl-chenodeoxycholic acid, 6-ethylchenodeoxycholic acid, Rattus norvegicus8, Gunn ratsfalseEffects of obeticholic acid on ileum microflora in BDL rats2023-05-172022-05-28PRJNA827104